Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK2 | Q16620 | 1/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29135918 | 0.86 | NTRK2 (0.35) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL10986346 | 0.81 | NTRK2 (0.38) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL193410 | 0.80 | CA12 (0.43) | CA12CA1CA9 | |
| SCHEMBL7846668 | 0.79 | CAMK2A (0.41) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL194060 | 0.77 | NTRK2 (0.36) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL8430870 | 0.77 | USP2 (0.37) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL10002584 | 0.77 | NTRK2 (0.40) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL6247927 | 0.75 | CAMK2A (0.38) | NTRK2CAMK2ACA12CA1CA9 | |
| SCHEMBL17291895 | 0.75 | LMNA (0.44) | NTRK2CAMK2AGPR84FFAR1FFAR4 | |
| SCHEMBL11595248 | 0.75 | CAMK2A (0.38) | NTRK2CAMK2ACA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255868-A1 | SANITIZING COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-08-17 | — | — | US | claimed |
| EP-4171489-A1 | SANITIZING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-05-03 | — | — | EP | claimed |
| WO-2022002882-A1 | SANITIZING COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-01-06 | — | — | WO | claimed |
| WO-2001089591-A2 | SURFACE-TREATED SUPERABSORBENT POLYMER PARTICLES | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-29 | — | — | WO | claimed |
| US-20240050342-A1 | PROLIPID COMPOSITION FOR PERSONALIZED BENEFITS AND METHOD FOR USING THE SAME | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-02-15 | — | — | US | disclosed |
| EP-3558245-B1 | TOPICAL SKIN LIGHTENING ADDITIVE AND COMPOSITION WITH AMINO ACIDS AND PPAR ACTIVATING FATTY ACIDS | UNILEVER IP HOLDINGS B V (NL) | 2024-02-07 | — | — | EP | disclosed |
| WO-2024002892-A1 | ANTI-ACNE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2024-01-04 | — | — | WO | disclosed |
| EP-4267255-A1 | PROLIPID COMPOSITION FOR PERSONALIZED BENEFITS AND METHOD FOR USING THE SAME | Unilever IP Holdings B.V. (NL) | 2023-11-01 | — | — | EP | disclosed |
| US-11759412-B2 | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | CONOPCO, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20230255868-A1 | SANITIZING COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4223765-A1 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | Genomatica, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| US-20230181433-A1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-06-15 | — | — | US | disclosed |
| EP-2148649-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House (GB) | 2010-02-03 | — | — | EP | disclosed |
| US-20080299054-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | CONOPCO, INC., D/B/A UNILEVER (US) | 2008-12-04 | — | — | US | disclosed |
| WO-2008145582-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | UNILEVER PLC (GB) | 2008-12-04 | — | — | WO | disclosed |
| EP-1715838-B1 | STABILIZATION WITH SUBSTITUTED UREAS AGAINST COLOR DEGRADATION OF PERSONAL CARE PRODUCTS | UNILEVER PLC (GB) | 2007-07-11 | — | — | EP | disclosed |
| EP-1715838-A1 | STABILIZATION WITH SUBSTITUTED UREAS AGAINST COLOR DEGRADATION OF PERSONAL CARE PRODUCTS | Unilever Plc (GB) | 2006-11-02 | — | — | EP | disclosed |
| WO-2005079740-A1 | STABILIZATION WITH SUBSTITUTED UREAS AGAINST COLOR DEGRADATION OF PERSONAL CARE PRODUCTS | UNILEVER PLC (GB) | 2005-09-01 | — | — | WO | disclosed |
| US-20050186231-A1 | Stabilization with substituted ureas against color degradation of personal care products | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-08-25 | — | — | US | disclosed |
| WO-2001089591-A2 | SURFACE-TREATED SUPERABSORBENT POLYMER PARTICLES | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299054-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY | CUTA, KAT5, PUF60 | NTRK2 4492/4885CAMK2A 4670/4885CA12 2098/4885 |
| US-20230181433-A1 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | GPX1, GPX4, GCLC | NTRK2 4158/4885CAMK2A 4761/4885CA12 4660/4885 |
| US-11759412-B2 | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids | GPX1, GPX4, GCLC | NTRK2 4158/4885CAMK2A 4761/4885CA12 4660/4885 |
| US-20050186231-A1 | Stabilization with substituted ureas against color degradation of personal care products | CUTA, PUF60, USP10 | NTRK2 4299/4885CAMK2A 4863/4885CA12 1570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.